Objective: To investigate the symptoms of lung cancer patients treated with immune checkpoint inhibitors and analyze the influencing factors, providing a reference for symptom management. Methods: A survey was conducted on 191 lung cancer patients treated with immune checkpoint inhibitors using a questionnaire based on the Chinese version of the “Treatment-Related Symptoms Checklist,” the Chinese version of the Medical Coping Modes Questionnaire, the Chinese Patient Health Questionnaire Depression Scale, and the Generalized Anxiety Disorder Scale. Results: The total symptom score for lung cancer patients treated with immune checkpoint inhibitors was (24.35 ± 10.32). For patients receiving combination therapies, the symptom score was (26.01 ± 9.93), while those receiving immune checkpoint inhibitor monotherapy had a score of (16.09 ± 8.15). Multiple linear regression results showed that body mass index, current treatment method, depression, and the “acceptance-resignation” coping style were major factors affecting symptoms in these patients. Conclusion: Patients with lung cancer treated with immune checkpoint inhibitors have a significant symptom burden. Those with a body mass index of 17.4 - 18.5 kg/m 2 , receiving immune checkpoint inhibitors combined with chemotherapy, or combined with chemotherapy and targeted therapy, with high depression scores and adopting an acceptance-resignationing coping style, experience more severe overall symptoms.
Chinese Medical Doctor Association Multidisciplinary Cancer Treatment Committee and National Cancer Quality Control Center Lung Cancer Quality Control Expert Committee (2025) Chinese Expert Consensus on Lung Cancer Immune Checkpoint Inhibitors Combined with Radiotherapy (2025 Edition). Chinese Journal of Oncology , 47, 39-64.
Filho, A.M., Laversanne, M., Ferlay, J., Colombet, M., Piñeros, M., Znaor, A., et al. (2024) The GLOBOCAN 2022 Cancer Estimates: Data Sources, Methods, and a Snapshot of the Cancer Burden Worldwide. International Journal of Cancer , 156, 1336-1346. https://doi.org/10.1002/ijc.35278
Li, Y., Liang, X., Li, H. and Chen, X. (2023) Efficacy and Safety of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer with or without PD-L1 Selection: A Systematic Review and Network Meta-Analysis. Chinese Medical Journal , 136, 2156-2165. https://doi.org/10.1097/cm9.0000000000002750
Ando, K., Manabe, R., Kishino, Y., Kusumoto, S., Yamaoka, T., Tanaka, A., et al. (2020) Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer—A Systematic Review and Network Meta-Analysis. Cancers , 13, Article 52. https://doi.org/10.3390/cancers13010052
Brahmer, J.R., Lacchetti, C., Schneider, B.J., Atkins, M.B., Brassil, K.J., Caterino, J.M., et al. (2018) Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology , 36, 1714-1768. https://doi.org/10.1200/jco.2017.77.6385
Williams, P.D., Lopez, V., Ying, C.S., Piamjariyakul, U., Wenru, W., Hung, G.T.Y., et al. (2010) Symptom Monitoring and Self-Care Practices among Oncology Adults in China. Cancer Nursing , 33, 184-193. https://doi.org/10.1097/ncc.0b013e3181c29598
Feifel, H., Strack, S. and Nagy, V.T. (1987) Coping Strategies and Associated Features of Medically Ill Patients. Psychosomatic Medicine , 49, 616-625. https://doi.org/10.1097/00006842-198711000-00007
Shen, X.H. and Jiang, Q.J. (2000) Test Report of the Chinese Version of the Medical Coping Modes Questionnaire on 701 Cases. Chinese Journal of Behavioral Medical Science , No. 1, 22-24.
Huang, J.X. (2020) Study on the Correlation Between Symptom Distress and Coping Styles in Esophageal Cancer Patients Undergoing Adjuvant Chemotherapy. Contemporary Nurse ( Mid - Month Edition ), 27, 124-126.
Spitzer, R.L., Kroenke, K., Williams, J.B.W. and Löwe, B. (2006) A Brief Measure for Assessing Generalized Anxiety Disorder. Archives of Internal Medicine , 166, 1092-1097. https://doi.org/10.1001/archinte.166.10.1092
Esser, P., Hartung, T.J., Friedrich, M., Johansen, C., Wittchen, H., Faller, H., et al. (2018) The Generalized Anxiety Disorder Screener (GAD-7) and the Anxiety Module of the Hospital and Depression Scale (HADS-A) as Screening Tools for Generalized Anxiety Disorder among Cancer Patients. Psycho - Oncology , 27, 1509-1516. https://doi.org/10.1002/pon.4681
Wang, Y., Chen, R. and Zhang, L. (2018) Reliability and Validity of the Generalized Anxiety Disorder Scale-7 in Chinese General Hospital Inpatients. Journal of Clinical Psychiatry , 28, 168-171.
Kroenke, K., Spitzer, R.L. and Williams, J.B.W. (2001) The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine , 16, 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Chen, R., Wang, Y., Yu, J.Y., et al. (2017) Reliability and Validity of the PHQ-9 in General Hospital Inpatients. Sichuan Mental Health , 30, 149-153.
Yang, Z.H., Luo, Y.Y., Lu, R.Q., et al. (2024) Evidence Summary for Management of Skin Toxicity Related to Tumor Immune Checkpoint Inhibitors. Journal of Nursing Science , 39, 46-50.
Schneider, B.J., Naidoo, J., Santomasso, B.D., Lacchetti, C., Adkins, S., Anadkat, M., et al. (2021) Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. Journal of Clinical Oncology , 39, 4073-4126. https://doi.org/10.1200/jco.21.01440
Chinese Society of Clinical Oncology Guideline Working Committee (2023) Chinese Society of Clinical Oncology (CSCO) Guidelines for the Management of Toxicities Related to Immune Checkpoint Inhibitors. 3rd Edition, People’s Medical Publishing House.
Chinese Society of Geriatric Medicine Dermatology Branch, Chinese Medical Association Dermatology and Venereology Branch and Chinese Medical Doctor Association Dermatologist Branch (2024) Chinese Expert Consensus on the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Related Skin Adverse Reactions (2024 Edition). National Medical Journal of China , 104, 1790-1803.
Shanghai Medical Association Dermatology and Venereology Branch and Shanghai Medical Association Tumor Target Molecular Specialty Branch (2023) Expert Consensus on the Management of Skin Adverse Reactions Related to Antitumor Drugs. Chinese Journal of Dermatology , 56, 907-919.
Chen, X.H., Wang, J.J. and Gao, Y.T. (2022) Study on the Correlation between Nutritional Status and Chemotherapy Adverse Reactions and Cancer-Related Fatigue in Lung Cancer Patients. Chinese Clinical Oncology and Rehabilitation , 29, 875-878.
Lei, L., Yue, C.L., Chen, D., et al. (2020) Study on the Correlation Between Malnutrition Risk and Cancer-Related Fatigue and Quality of Life in Lung Cancer Patients. Progress in Modern Biomedicine , 20, 4780-4784.
Shen, Y., Wang, X.A., He, T., et al. (2018) Study on the Relationship between Body Mass Index and Postoperative Complications and Mortality in Lung Cancer Patients. Sichuan Medical Journal , 39, 1151-1155.
Nie, W., Lu, J., Qian, J., Wang, S., Cheng, L., Zheng, L., et al. (2024) Obesity and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Chemotherapy, Immunotherapy, or Chemoimmunotherapy: A Multicenter Cohort Study. BMC Medicine , 22, Article No. 463. https://doi.org/10.1186/s12916-024-03688-2
Polański, J., Tański, W., Dudek, K. and Jankowska-Polańska, B. (2024) Pain and Coping Strategies as Determinants of Malnutrition Risk in Lung Cancer Patients: A Cross-Sectional Study. Nutrients , 16, Article 2193. https://doi.org/10.3390/nu16142193
Shen, S., Xing, S., Shen, T., Niu, L., Tian, X., Ma, H., et al. (2025) Nutritional Risk, Functional Decline, and Symptom Burden in Lung Cancer: A Study Based on PG-SGA Scores and Biochemical Data. Frontiers in Nutrition , 12, Article 1545177. https://doi.org/10.3389/fnut.2025.1545177
Chinese Society of Parenteral and Enteral Nutrition (2017) Guidelines for Nutritional Support in Cancer Patients. Chinese Journal of Surgery , 55, 801-829.
Baguley, B.J., Skinner, T.L. and Wright, O.R.L. (2019) Nutrition Therapy for the Management of Cancer-Related Fatigue and Quality of Life: A Systematic Review and Meta-Analysis. British Journal of Nutrition , 122, 527-541. https://doi.org/10.1017/s000711451800363x
He, Q., Han, Y.H., Xu, K., et al. (2019) Study on Treatment-Related Symptoms and Influencing Factors in Lung Cancer Patients. Journal of Nursing Science , 34, 10-14.
Stylianou, C., Kalemikerakis, I., Konstantinidis, T., Kafazi, A., Alevizopoulos, N., Parissopoulos, S., et al. (2024) Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy. Medicina , 60, Article 1845. https://doi.org/10.3390/medicina60111845
Du, R., Wang, X., Zhou, H., Ma, L., Larcher, L.M., Chen, C., et al. (2022) The Health-Related Quality of Life of Lung Cancer Patients with EGFR-TKI-Related Skin Adverse Drug Reactions and Its Relationship with Coping Style and Self-Management. Supportive Care in Cancer , 30, 9889-9899. https://doi.org/10.1007/s00520-022-07451-2
Wong, W.S. and Fielding, R. (2006) Quality of Life and Pain in Chinese Lung Cancer Patients: Is Optimism a Moderator or Mediator? Quality of Life Research , 16, 53-63. https://doi.org/10.1007/s11136-006-9106-z
Fan, H.J., Ju, L.L., Ge, Y.Y., et al. (2024) Correlation between Social Support, Post-Traumatic Stress Response, and Coping Styles in Breast Cancer Patients Undergoing Radiotherapy. Modern Journal of Integrated Traditional Chinese and Western Medicin e , 33, 2592-2596.
Guo, T.T., Xing, W., Guo, L.Y., et al. (2020) The Relationship between Coping Styles and Quality of Life in Ovarian Cancer Patients: The Mediating Role of Fear of Disease Progression. Modern Preventive Medicine , 47, 1803-1806.
Lin, S.Y., Wu, Y., Lin, B.L., et al. (2021) Survey and Correlation Analysis of Quality of Life, Coping Styles, and Attitude towards Death in Postoperative Cervical Cancer Patients. Cancer Prevention and Treatment , 34, 1063-1068.
Tao, F.F. and Liu, L. (2025) Analysis of Psychological Resilience Status and Influencing Factors in Middle-Aged and Young Lung Cancer Patients. General Nursi ng , 23, 2143-2147.
Jiang, Y.L., Chen, Y.R., Han, B., et al. (2021) The Effect of Nursing Intervention Based on the Psychological Resilience Development Model on Self-Management Ability, Psychological Resilience, Disease Uncertainty, and Coping Styles in Patients Undergoing Laparoscopic Ovarian Cancer Resection. Clinical Medicine Research and Practice , 6, 153-155.
van de Wiel, M., Derijcke, S., Galdermans, D., Daenen, M., Surmont, V., De Droogh, E., et al. (2021) Coping Strategy Influences Quality of Life in Patients with Advanced Lung Cancer by Mediating Mood. Clinical Lung Cancer , 22, e146-e152. https://doi.org/10.1016/j.cllc.2020.09.010
Yin, Y., Lyu, M., Chen, Y., Zhang, J., Li, H., Li, H., et al. (2022) Self-Efficacy and Positive Coping Mediate the Relationship between Social Support and Resilience in Patients Undergoing Lung Cancer Treatment: A Cross-Sectional Study. Frontiers in Psychology , 13, Article 953491. https://doi.org/10.3389/fpsyg.2022.953491
Zang, Y., Zhao, J.M. and Qi, W.J. (2018) Study on Symptom Clusters in Lung Cancer Patients and Their Correlation with Anxiety and Depression. Nursing Research , 32, 384-387.
Zhang, X. and Zhang, X. (2017) Somatization Symptoms in Lung Cancer Patients and Correlative Analysis between Anxiety, Depression and Somatization Symptoms. Chinese Journal of Lung Cancer , 20, 473-478.
Wang, X., Ma, X., Yang, M., Wang, Y., Xie, Y., Hou, W., et al. (2022) Proportion and Related Factors of Depression and Anxiety for Inpatients with Lung Cancer in China: A Hospital-Based Cross-Sectional Study. Supportive Care in Cancer , 30, 5539-5549. https://doi.org/10.1007/s00520-022-06961-3
Gonzalez-Ling, A., Galindo Vázquez, O., Espinoza Bello, M., Robles, R., Rascón-Gasca, M.L., Lara-Mejía, L., et al. (2022) Quality of Life, Anxiety, Depression, and Distress in Patients with Advanced and Metastatic Lung Cancer. Palliative and Supportive Care , 21, 608-615. https://doi.org/10.1017/s147895152200116x
Hu, Y., Xiao, L.D., Tang, C., Cao, W. and Wang, Y. (2024) Prevalence and Risk Factors of Sleep Disturbances among Patients with Lung Cancer: Systematic Review and Meta-Analysis. Supportive Care in Cancer , 32, Article No. 619. https://doi.org/10.1007/s00520-024-08798-4
Ma, L., Li, H. and Li, X.H. (2016) Correlation between Cancer-Related Fatigue and Depression in Lymphoma Chemotherapy Patients. China Medical Herald , 13, 97-100.
Zhu, Y., Xiong, J.S., Gu, C.R., et al. (2018) The Impact of Depression on the Quality of Life in Advanced Lung Cancer Patients During Palliative Care. Anhui Medical and Pharmaceutical Journal , 22, 2394-2396.
Ye, M., Feng, Zh.Z., Liu, K.Y., et al. (2013) The Impact of Depression on Quality of Life in Patients with Advanced Malignant Tumors. Oncology Research and Clinical , 25, 260-262.